Previous Page  32 / 65 Next Page
Information
Show Menu
Previous Page 32 / 65 Next Page
Page Background

Davidoff vs. The FDA

Davidoff is among those cigar companies fortunate

enough to have products that will be grandfathered into

the FDA’s plan. Its premium cigar portfolio covers all of

the price points that will help it move forward. There are

premium bundles under the Cusano brand, fresh-pack

cigars for the convenience channel and private label

brands for brick-and-mortar stores, as well as mail-or-

der and distributor channels. Davidoff will also build

on the momentum and growth it has seen over the past

few years with its core brands—Davidoff, Camacho and

Avo. At full view, Davidoff offers a full range of products

in terms of price, origin and intensity for its appoint-

ed merchants and other tobacconists. It’s also increased

its retail footprint with new Davidoff-branded stores, li-

censed boutiques and Davidoff Lounges.

The FDA regulations have forced Davidoff on an un-

expected and challenging course, but it’s one the compa-

ny doesn’t plan to shy away from. “Davidoff of Geneva

USA is absolutely determined to be in good shape on the

other side of this FDA challenge and we will work with

our industry colleagues and customers to get the best

outcome possible for the entire premium cigar industry,”

says Young. “I truly am incredibly proud of my team,

my colleagues and our partners in terms of how we have

embraced the challenge.”

Young and his team have adapted as best they can to

the challenges set forth by the FDA in recent months.

When asked how exactly the new regulations have

changed how they do business, Young responds that first

and foremost the FDA has forced those at Davidoff to

learn firsthand what other previously regulated tobac-

co products and companies have been going through

for years. Young and his team have spent an incredible

amount of time trying to explain to the government and

lawmakers the difference between cigarettes and premi-

um cigars, a necessary step toward getting an exemption

for premium cigars or regulation that makes sense.

Davidoff’s Indispensable

Business Partners

While important, FDA compliance is just one focus of

Davidoff’s overall mission and strategy going forward.

Another important part of the company’s marketing

plan is nurturing strong relationships with its retail part-

ners. Davidoff sees itself as an indispensable business

partner to its customers, beginning with its appointed

merchants. This has been part of Davidoff’s marketing

initiatives since 2012 and has grown more important in

the years following.

“The Indispensable Business Partner program was born

out of a study we conducted comparing the relative per-

formance of our appointed merchants with the degree to

which they executed key consumer activities such as events,

merchandising, assortment, training and education, store

look and its feel,” Young says. “We found very compelling

learnings out of that study and, in collaboration with our

Retail Advisory Board, set about laying out our strategic

priorities in terms of channel and customer development,

aligning significantly increased resources, tailoring game

plans by account and, finally, building a customer incentive

program and a merchant recognition program—the Gold-

en Band Awards, our version of the Oscars.”

The Cigars of Past, Present and Future

In addition to working closely with its merchant and re-

tail partners, Davidoff also has invested a lot of time and

marketing efforts into its core portfolio. The company

has clear strategies and plans in place for its Davidoff,

Avo and Camacho brands, which include identifying

each brand’s message to consumers and determining

how each brand will be marketed differently to continue

to thrive in today’s marketplace.

“We have done some important work on the balance

of the portfolio and will continue to do that going for-

ward,” Young explains. “The FDA has disrupted some

of those plans for now, but we have a portfolio that is

stacked with very good cigars, produced under a set of

standards admired and respected by the industry, our re-

tailers and consumers.”

[ 32 ]

TOBACCO BUSINESS

[

MARCH

/

APRIL

|

17 ]

The U.S.

market is the

number one

premium cigar

market in the

world and we

do not see that

changing—FDA

or no FDA.